Cortexyme Alzheimer's study placed on partial clinical hold BioWorld Online ... read more
Source: Google NewsPublished on 2021-02-16
Related Articles:
- The road ahead: 2021 January 25, 2021 # # # # At the start of each year, it is a useful practise to layout what is planned over the next 12 months. The events that are scheduled for the year to come, so that we can keep an eye out for them. Obviously, where 2021 will end actually is unpredictable, but an outline of what is scheduled…
- 2019: Year in review December 31, 2019 In this end-of-year post, we review the Parkinson’s research that caught our attention at SoPD HQ in 2019. Month-by-month we will briefly discuss some of the major pieces of research/announcements that have defined the year and advanced our understanding of Parkinson’s. The list is based on nothing more than the author’s personal opinion – apologies to any researchers who…
- The road ahead: 2020 January 5, 2020 Here at the SoPD, we are primarily interested in disease modification for Parkinson’s. While there is a great deal of interesting research exploring the causes of the condition, novel symptomatic therapies, and other aspects of Parkinson’s, my focus is generally on the science seeking to slow, stop or reverse the condition. At the start of each year, it is a…
- BioWorld MedTech's Diagnostics Extra for Jan. 7, 2021 | 2021-01-07 | BioWorld - BioWorld Online January 7, 2021 BioWorld MedTech's Diagnostics Extra for Jan. 7, 2021 | 2021-01-07 | BioWorld BioWorld Online
- BioWorld MedTech's Neurology Extra for Jan. 8, 2021 | 2021-01-08 | BioWorld - BioWorld Online January 8, 2021 BioWorld MedTech's Neurology Extra for Jan. 8, 2021 | 2021-01-08 | BioWorld BioWorld Online
- BioWorld MedTech Patent Highlights: Week 53 | 2021-01-08 | BioWorld - BioWorld Online January 8, 2021 BioWorld MedTech Patent Highlights: Week 53 | 2021-01-08 | BioWorld BioWorld Online
- Monthly Research Review – January 2021 January 31, 2021 # # # # At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during the previous 4 weeks. The post is divided into eight parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical…
- Pfizer, Verily-backed Alzheimer's biotech Cortexyme hit by FDA partial hold over liver toxicity - FierceBiotech February 16, 2021 Pfizer, Verily-backed Alzheimer's biotech Cortexyme hit by FDA partial hold over liver toxicity FierceBiotech
- BioWorld MedTech's Neurology Extra for Jan. 29, 2021 | 2021-01-29 - BioWorld Online January 29, 2021 BioWorld MedTech's Neurology Extra for Jan. 29, 2021 | 2021-01-29 BioWorld Online
- BioWorld MedTech's Neurology Extra for Feb. 5, 2021 | 2021-02-05 - BioWorld Online February 5, 2021 BioWorld MedTech's Neurology Extra for Feb. 5, 2021 | 2021-02-05 BioWorld Online
- Inflazome gets funding from Michael J. Fox Foundation for Parkinson's R&D - BioWorld Online March 26, 2019 Inflazome gets funding from Michael J. Fox Foundation for Parkinson's R&D BioWorld OnlineBioWorld Online is the news *service* of record for the biotechnology industry and is updated every business morning. BioWorld Online will keep you up to date ...
- Investors bullish on companies focused on neurological diseases - BioWorld Online May 11, 2019 Investors bullish on companies focused on neurological diseases BioWorld OnlineBioWorld Online is the news *service* of record for the biotechnology industry and is updated every business morning. BioWorld Online will keep you up to date ...
- Fountain Healthcare Partners closes third fund at $132M - BioWorld Online May 23, 2019 Fountain Healthcare Partners closes third fund at $132M BioWorld OnlineBioWorld Online is the news *service* of record for the biotechnology industry and is updated every business morning. BioWorld Online will keep you up to date ...
- Bayer goes all in on Bluerock, paying $240M up front for cell therapy firm - BioWorld Online August 8, 2019 Bayer goes all in on Bluerock, paying $240M up front for cell therapy firm BioWorld OnlineBioWorld Online is the news *service* of record for the biotechnology industry and is updated every business morning. BioWorld Online will keep you up to date ...
- Shining a light on Parkinson’s November 7, 2019 NOTE: The information in today’s post should not be considered an endorsement of PhotoPharmics or the treatment they are proposing. The author of this blog has had no communication with the company. The information in this post is provided because the author has been asked by readers to discuss it. In October 2018, at the annual International Movement Disorders…
- FDA puts Parkinson's trial on hold amid imaging abnormalities - BioWorld Online December 23, 2020 FDA puts Parkinson's trial on hold amid imaging abnormalities BioWorld Online
- Cortexyme Announces Pipeline Update and Anticipated 2021 Milestones - Yahoo Finance January 26, 2021 Cortexyme Announces Pipeline Update and Anticipated 2021 Milestones Yahoo Finance
- Cortexyme Announces Pipeline Update and Anticipated 2021 Milestones | Business | valdostadailytimes.com - Valdosta Daily Times January 26, 2021 Cortexyme Announces Pipeline Update and Anticipated 2021 Milestones | Business | valdostadailytimes.com Valdosta Daily Times
- Cortexyme Announces Pipeline Update and Anticipated 2021 Milestones - BioSpace January 26, 2021 Cortexyme Announces Pipeline Update and Anticipated 2021 Milestones BioSpace
- Cortexyme to start testing its lead candidate in Parkinson’s disease - Seeking Alpha January 26, 2021 Cortexyme to start testing its lead candidate in Parkinson’s disease Seeking Alpha
- Alzheimer's disease subtypes may explain, improve clinical results - BioWorld Online January 13, 2021 Alzheimer's disease subtypes may explain, improve clinical results BioWorld Online
- Monthly research review: February 2020 February 29, 2020 At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during February 2020. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Other news Review…